当前位置: X-MOL 学术JAMA Intern. Med. › 论文详情
Oral Anticoagulants, Proton Pump Inhibitors, and Fracture—Reply
JAMA Internal Medicine ( IF 20.768 ) Pub Date : 2020-04-01 , DOI: 10.1001/jamainternmed.2020.0271
Pamela L. Lutsey; Faye L. Norby; Alvaro Alonso

In Reply We thank Uzoigwe and colleagues for their careful consideration of our article,1 which reported that among patients with atrial fibrillation (AF), fracture risk was lower among users of direct oral anticoagulants (DOACs), particularly apixaban, compared with users of warfarin. Uzoigwe and colleagues suggest an alternate explanation for our findings: that confounding by use of proton pump inhibitors (PPIs) may underlie the differences we observed. This hypothesis is intriguing, given the high prevalence of PPI prescriptions among older adults2,3 combined with evidence linking PPIs to fracture risk.4 We had not previously explicitly considered PPIs; however, confounding by PPI use should have been mitigated through our rigorous approach to minimize confounding, particularly via the use of high-dimensional propensity scores, which incorporated all available information on pharmacy prescription fills, inpatient and outpatient diagnostic codes, and inpatient and outpatient procedure codes.
更新日期:2020-04-01

 

全部期刊列表>>
聚焦商业经济政治法律
智控未来
控制与机器人
化学研究精选
欢迎探索2019年最具下载量的地球科学论文
招募海内外科研人才,上自然官网
基因组学对精准公共卫生的影响,专辑征稿
隐藏1h前已浏览文章
课题组网站
新版X-MOL期刊搜索和高级搜索功能介绍
ACS材料视界
x-mol收录
湖南大学化学化工学院刘松
上海有机所
李旸
大连化物所
香港大学
X-MOL
支志明
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug